Free public records show Fougera Pharmaceuticals in 1 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
79 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Fougera Pharmaceuticals: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Fougera Pharmaceuticals is in.
Stories on the topics Fougera Pharmaceuticals works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
Breast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to…
ReadSearch all reports for Fougera Pharmaceuticals All companies